Favorable Antiviral Effect of Metformin on SARS-CoV-2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of COVID-19.

Bramante CT, Beckman KB, Mehta T, Karger AB, Odde DJ, Tignanelli CJ, Buse JB, Johnson DM, Watson RHB, Daniel JJ, Liebovitz DM, Nicklas JM, Cohen K, Puskarich MA, Belani HK, Siegel LK, Klatt NR, Anderson B, Hartman KM, Rao V, Hagen AA, Patel B, Fenno SL, Avula N, Reddy NV, Erickson SM, Fricton RD, Lee S, Griffiths G, Pullen MF, Thompson JL, Sherwood NE, Murray TA, Rose MR, Boulware DR, Huling JD, COVID-OUT Study Team

Open source

DOI: 10.1093/cid/ciae159
Published: 2024 Aug 16
Container: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/cid/ciae159,
  title = {Favorable Antiviral Effect of Metformin on SARS-CoV-2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of COVID-19.},
  author = {Bramante CT and Beckman KB and Mehta T and Karger AB and Odde DJ and Tignanelli CJ and Buse JB and Johnson DM and Watson RHB and Daniel JJ and Liebovitz DM and Nicklas JM and Cohen K and Puskarich MA and Belani HK and Siegel LK and Klatt NR and Anderson B and Hartman KM and Rao V and Hagen AA and Patel B and Fenno SL and Avula N and Reddy NV and Erickson SM and Fricton RD and Lee S and Griffiths G and Pullen MF and Thompson JL and Sherwood NE and Murray TA and Rose MR and Boulware DR and Huling JD and COVID-OUT Study Team},
  year = {2024},
  journal = {Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  doi = {10.1093/cid/ciae159},
  url = {https://doi.org/10.1093/cid/ciae159}
}

RIS

TY  - JOUR
TI  - Favorable Antiviral Effect of Metformin on SARS-CoV-2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of COVID-19.
AU  - Bramante CT
AU  - Beckman KB
AU  - Mehta T
AU  - Karger AB
AU  - Odde DJ
AU  - Tignanelli CJ
AU  - Buse JB
AU  - Johnson DM
AU  - Watson RHB
AU  - Daniel JJ
AU  - Liebovitz DM
AU  - Nicklas JM
AU  - Cohen K
AU  - Puskarich MA
AU  - Belani HK
AU  - Siegel LK
AU  - Klatt NR
AU  - Anderson B
AU  - Hartman KM
AU  - Rao V
AU  - Hagen AA
AU  - Patel B
AU  - Fenno SL
AU  - Avula N
AU  - Reddy NV
AU  - Erickson SM
AU  - Fricton RD
AU  - Lee S
AU  - Griffiths G
AU  - Pullen MF
AU  - Thompson JL
AU  - Sherwood NE
AU  - Murray TA
AU  - Rose MR
AU  - Boulware DR
AU  - Huling JD
AU  - COVID-OUT Study Team
PY  - 2024
JO  - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
DO  - 10.1093/cid/ciae159
UR  - https://doi.org/10.1093/cid/ciae159
ER  -

APA

CT, B., KB, B., T, M., AB, K., DJ, O., CJ, T., JB, B., DM, J., RHB, W., JJ, D., DM, L., JM, N., K, C., MA, P., HK, B., LK, S., NR, K., B, A., KM, H., V, R., AA, H., B, P., SL, F., N, A., NV, R., SM, E., RD, F., S, L., G, G., MF, P., JL, T., NE, S., TA, M., MR, R., DR, B., JD, H., & Team, C. S. (2024). Favorable Antiviral Effect of Metformin on SARS-CoV-2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of COVID-19.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. https://doi.org/10.1093/cid/ciae159

Source records

pubmed · retrieved 2026-09-26T18:14:45.042Z